Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Neoplasms × Dasatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17 Breast Neoplasms 15 Leukemia 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myeloid, Chronic-Phase 10 Recurrence 8 Prostatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Melanoma 5 Burkitt Lymphoma 5 Pancreatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Blast Crisis 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Neoplasms 3 Lymphoma 3 Gliosarcoma 3 Sarcoma 2 Salivary Gland Neoplasms 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Polycythemia Vera 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

Paclitaxel 6 Radiotherapy 2 Pemetrexed 2 Carboplatin 2 Brachytherapy 2 tucatinib 1 seribantumab 1 osimertinib 1 gedatolisib 1 fosaprepitant 1 fluciclovine F-18 1 cobimetinib 1 atezolizumab 1 alovudine 1 Trastuzumab 1 Therapeutics 1 TP protocol 1 Saline Solution 1 Radiation 1 Protons 1 Palliative Care 1 Nivolumab 1 Letrozole 1 Immunoglobulin G 1 Imatinib Mesylate 1 Ifosfamide 1 Gemcitabine 1 Fulvestrant 1 FANG vaccine 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡